MONIQUE OLIVARES: Open Payments
NPI 1629329099 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,279 in 94 payments from 18 companies in 2025. Trend: 2023 $2,138 · 2024 $2,991 · 2025 $2,279
Food & beverage: $2,102Education: $177
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 17 | $481 |
| ABBVIE INC. | 17 | $324 |
| Lilly USA, LLC | 11 | $229 |
| GENZYME CORPORATION | 7 | $201 |
| Galderma Laboratories, L.P. | 4 | $191 |
| Regeneron Healthcare Solutions, Inc. | 7 | $174 |
| LEO Pharma Inc. | 8 | $172 |
| E.R. Squibb & Sons, L.L.C. | 4 | $75 |
| Incyte Corporation | 3 | $72 |
| UCB, Inc. | 2 | $69 |
Products named: TREMFYA, DUPIXENT, TALTZ, SKYRIZI, NEMLUVIO, ADBRY, RINVOQ, Sotyktu.
Industry payments across NY — which companies pay providers there.
